411 related articles for article (PubMed ID: 30785609)
1. Comparative Effectiveness of Adjunctive Psychotropic Medications in Patients With Schizophrenia.
Stroup TS; Gerhard T; Crystal S; Huang C; Tan Z; Wall MM; Mathai C; Olfson M
JAMA Psychiatry; 2019 May; 76(5):508-515. PubMed ID: 30785609
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
[TBL] [Abstract][Full Text] [Related]
3. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
4. Racial differences in the use of adjunctive psychotropic medications for patients with schizophrenia.
Mallinger JB; Lamberti SJ
J Ment Health Policy Econ; 2007 Mar; 10(1):15-22. PubMed ID: 17417044
[TBL] [Abstract][Full Text] [Related]
5. Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia.
Puranen A; Koponen M; Tanskanen A; Tiihonen J; Taipale H
Eur J Clin Pharmacol; 2020 May; 76(5):711-718. PubMed ID: 31940085
[TBL] [Abstract][Full Text] [Related]
6. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
7. Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder.
Lähteenvuo M; Tanskanen A; Taipale H; Hoti F; Vattulainen P; Vieta E; Tiihonen J
JAMA Psychiatry; 2018 Apr; 75(4):347-355. PubMed ID: 29490359
[TBL] [Abstract][Full Text] [Related]
8. Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia.
Tiihonen J; Suokas JT; Suvisaari JM; Haukka J; Korhonen P
Arch Gen Psychiatry; 2012 May; 69(5):476-83. PubMed ID: 22566579
[TBL] [Abstract][Full Text] [Related]
9. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
10. Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study.
Tiihonen J; Mittendorfer-Rutz E; Torniainen M; Alexanderson K; Tanskanen A
Am J Psychiatry; 2016 Jun; 173(6):600-6. PubMed ID: 26651392
[TBL] [Abstract][Full Text] [Related]
11. Benzodiazepine use and risk of mortality among patients with schizophrenia: a retrospective longitudinal study.
Fontanella CA; Campo JV; Phillips GS; Hiance-Steelesmith DL; Sweeney HA; Tam K; Lehrer D; Klein R; Hurst M
J Clin Psychiatry; 2016 May; 77(5):661-7. PubMed ID: 27249075
[TBL] [Abstract][Full Text] [Related]
12. Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.
Tiihonen J; Mittendorfer-Rutz E; Majak M; Mehtälä J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tanskanen A; Taipale H
JAMA Psychiatry; 2017 Jul; 74(7):686-693. PubMed ID: 28593216
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008.
Tor PC; Ng TP; Yong KH; Sim K; Xiang YT; Wang CY; Lee EH; Fujii S; Yang SY; Chong MY; Ungvari GS; Si T; He YL; Chung EK; Chee KY; Trivedi J; Udomratn P; Shinfuku N; Kua EH; Tan CH; Sartorius N; Baldessarini RJ
Int J Neuropsychopharmacol; 2011 Jul; 14(6):735-45. PubMed ID: 21294941
[TBL] [Abstract][Full Text] [Related]
14. Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.
Fontanella CA; Bridge JA; Campo JV
Ann Pharmacother; 2009 Dec; 43(12):1939-47. PubMed ID: 19934394
[TBL] [Abstract][Full Text] [Related]
15. Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia.
Broder MS; Bates JA; Jing Y; Hebden T; Forbes RA; Chang E
J Med Econ; 2012; 15(1):105-11. PubMed ID: 21991926
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia.
Stroup TS; Gerhard T; Crystal S; Huang C; Olfson M
Am J Psychiatry; 2016 Feb; 173(2):166-73. PubMed ID: 26541815
[TBL] [Abstract][Full Text] [Related]
17. Concomitant medications may not improve outcome of antipsychotic monotherapy for stabilized patients with nonacute schizophrenia.
Glick ID; Pham D; Davis JM
J Clin Psychiatry; 2006 Aug; 67(8):1261-5. PubMed ID: 16965205
[TBL] [Abstract][Full Text] [Related]
18. Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients.
Hartikainen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
JAMA Psychiatry; 2023 Jan; 80(1):31-39. PubMed ID: 36383348
[TBL] [Abstract][Full Text] [Related]
19. Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide.
Montastruc F; Nie R; Loo S; Rej S; Dell'Aniello S; Micallef J; Suissa S; Renoux C
JAMA Psychiatry; 2019 Apr; 76(4):409-417. PubMed ID: 30698607
[TBL] [Abstract][Full Text] [Related]
20. Use of Benzodiazepines and Antipsychotic Drugs Are Inversely Associated With Acute Readmission Risk in Schizophrenia.
Strømme MF; Mellesdal LS; Bartz-Johannesen CA; Kroken RA; Krogenes ML; Mehlum L; Johnsen E
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):37-42. PubMed ID: 34928559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
